-
-
-
-
-
-
-
Laidlaw Reiterates Buy Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Viking Therapeutics to Report Financial Results for Second Quarter 2025 on July 23, 2025
-
-
-
-
-
-
-
Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Viking Therapeutics to Report Financial Results for Third Quarter 2024 on October 23, 2024
-
-
-
-
-
-
-
Ligand Reports First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Tops Q4 EPS by 1c
-
1,206,955 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

